Rheumatoid arthritis (RA) is an autoimmune disease that causes the body’s immune system to attack joint tissues, which leads to inflammation of joint lining. Such inflammation of joint lining causes pain, stiffness, swelling, warmth, and redness. Rheumatoid arthritis is most prevalent among women. RA can be diagnosed through two methods, namely X–ray imaging and blood tests/serology test.
View Detail Report With TOC: http://www.persistencemarketresearch.com/market-research/rheumatoid-arthritis-market.asp
Global rheumatoid arthritis diagnosis tests market has been estimated to be valued at US$ 485.5 Mn in 2015, and is anticipated to increase to US$ 738.7 Mn by 2022, registering a CAGR of 6.2% during the forecast period. Incidence of RA are increasing among children in Europe and North America. This increased incidence rate calls for adoption of minimally-invasive test methods to diagnose rheumatoid arthritis. Hence, there is high demand for RA test kits with minimally-invasive testing method in Europe and North America.
By test type, the global rheumatoid arthritis diagnosis tests market is segmented into serology test and RA treatment efficiency monitoring tests. Serology test segment is further sub-segmented into erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid test, and other tests. RA treatment efficiency monitoring tests segment is further sub-segmented into Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), and Creatinine Test.
By end user, the global rheumatoid arthritis diagnosis tests market is segmented into a hospital, diagnostic laboratories, and ambulatory surgical centers. Diagnostic laboratory segment is further sub-segmented into private laboratories and public laboratories.
By region, the global rheumatoid arthritis diagnosis tests market is segmented into North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. Europe and Asia Pacific regions have been estimated to account for 61% market share in 2015.
Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/4788
Key players operating in the Rheumatoid Arthritis market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.